R
Ryanair Holdings PLC
DUS:RY4C
Ryanair Holdings PLC
DUS:RY4C
Price:
23.38
EUR
-2.38%
Market Cap:
€26.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Ryanair Holdings PLC
DUS:RY4C
|
IE |
|
Amadeus IT Group SA
OTC:AMADF
|
ES |
|
Brown-Forman Corp
NYSE:BF.B
|
US |
|
North American Construction Group Ltd
NYSE:NOA
|
CA |
|
R
|
Rockwell Automation Inc
F:RWL
|
US |
|
C
|
Chefs' Warehouse Inc
SWB:2CF
|
US |
|
Ajinomoto Co Inc
OTC:AJINY
|
JP |
|
H
|
HALEON PLC
XHAM:H6D0
|
UK |
|
Li Ning Co Ltd
F:LNLB
|
CN |
|
B
|
Bayer AG
OTC:BAYRY
|
DE |
|
Toyota Motor Corp
TSE:7203
|
JP |
|
C
|
Coherus BioSciences Inc
SWB:8C5
|
US |
|
E
|
Exor NV
SWB:EYX
|
NL |
|
Roche Holding AG
LSE:0QQ6
|
CH |
|
Pro Medicus Ltd
ASX:PME
|
AU |
|
Loomis AB
OTC:LOIMF
|
SE |
|
M
|
MetLife Inc
LSE:0K0X
|
US |
|
R
|
Rio Tinto Ltd
XHAM:CRA1
|
AU |
|
C
|
China Merchants Port Holdings Co Ltd
SWB:CPM
|
HK |
|
E
|
Exxon Mobil Corp
F:XONA
|
US |
|
M
|
MS&AD Insurance Group Holdings Inc
XBER:59M
|
JP |
|
E
|
Equifax Inc
XBER:EFX
|
US |
|
Spero Therapeutics Inc
NASDAQ:SPRO
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of RY4C.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RY4C
Multiples-Based Value
Not Available
